GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neuroscientific Biopharmaceuticals Ltd (ASX:NSB) » Definitions » Inventories, Raw Materials & Components

Neuroscientific Biopharmaceuticals (ASX:NSB) Inventories, Raw Materials & Components : A$0.00 Mil (As of Dec. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Neuroscientific Biopharmaceuticals Inventories, Raw Materials & Components?

Neuroscientific Biopharmaceuticals's inventories, raw materials & components for the quarter that ended in Dec. 2023 was A$0.00 Mil.


Neuroscientific Biopharmaceuticals Inventories, Raw Materials & Components Historical Data

The historical data trend for Neuroscientific Biopharmaceuticals's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neuroscientific Biopharmaceuticals Inventories, Raw Materials & Components Chart

Neuroscientific Biopharmaceuticals Annual Data
Trend Jun19 Jun20 Jun21 Jun22 Jun23
Inventories, Raw Materials & Components
- - - - -

Neuroscientific Biopharmaceuticals Semi-Annual Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Neuroscientific Biopharmaceuticals Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.


Neuroscientific Biopharmaceuticals (ASX:NSB) Business Description

Traded in Other Exchanges
N/A
Address
85 Forrest Street, Suite 5, Cottesloe, Perth, WA, AUS, 6011
Neuroscientific Biopharmaceuticals Ltd is an Australian-based biotechnology company. The company is engaged in the development of diagnostic and therapeutic treatments for neurodegenerative diseases through preclinical studies of patented technologies.

Neuroscientific Biopharmaceuticals (ASX:NSB) Headlines

No Headlines